MyOme is a leading clinical whole-genome analysis platform company, specializing in polygenic risk modeling (PRS). MyOme is dedicated to helping families understand their risk for inherited diseases by leveraging the power of whole-genome analysis to provide a lifetime of meaningful and actionable health insights. The company operates under the highest standards, holding certifications from both the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP).
